Participants react to failed HIV vaccine trial

Researchers are continuing to monitor participants of the HVTN 702 trial in South Africa, following last week's announcement that the HIV candidate vaccine that was tested has proven to be ineffective. According to Community Liaison Officer, Cynthia Mpongo who works at the Emavundleni Clinical Research Site in Cape Town, participants are also not losing hope and are still willing to be monitored, even though the vaccine will no longer be administered. Mpongo spoke to Channel Africa about the reaction of the over 400 participants enrolled at Emavundleni, one of the 14 research sites of the large scale trial conducted across the country..